Clinical Trials Browser

Phase 2/3 × Glutamine × Tumor-Agnostic × Clear all

NCT04710290 2021-01-25

A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers

Phase 2/3 Unknown

Neoplasm Metastasis